HealthStream Reports Record Q4 Revenue, Strong Non-GAAP Growth, Increases Dividend, and Completes Share Repurchase

summarizeSummary

HealthStream announced record fourth-quarter revenue and strong non-GAAP profitability, alongside a significant dividend increase, completion of a share repurchase program, and two strategic acquisitions, providing positive guidance for 2026.

check_boxKey Events

• Record Q4 2025 Revenue Achieved

  HealthStream reported record quarterly revenue of $79.7 million for the fourth quarter of 2025, representing a 7.4% increase from the prior year.

• Strong Non-GAAP Profitability and Adjusted EBITDA Growth

  Despite a GAAP net income decrease primarily due to a $3.8 million CEO stock gift to employees, non-GAAP net income rose 9.5% in Q4 2025, and Adjusted EBITDA increased 16.4% to $18.8 million.

• Quarterly Cash Dividend Increased by 12.9%

  The Board of Directors declared a quarterly cash dividend of $0.035 per share, marking a significant 12.9% increase over the previous quarter's dividend.

• Completed Share Repurchase Program

  The company completed its $10.0 million share repurchase program in January 2026, having repurchased a total of $30.0 million in common stock during 2025.

auto_awesomeAnalysis

This 8-K filing details HealthStream's strong financial and strategic performance for Q4 and full-year 2025, alongside positive forward-looking actions. The company reported record quarterly revenue and robust growth in non-GAAP profitability metrics like Adjusted EBITDA, which increased 16.4% in Q4. While GAAP net income saw a decline, this was primarily attributed to a $3.8 million CEO stock gift to employees, a unique event demonstrating strong internal alignment and employee retention efforts, rather than operational weakness. Strategically, HealthStream completed two significant acquisitions, Virsys12 and MissionCare Collective, which are expected to expand its healthcare technology platform and market reach. The company also demonstrated a commitment to shareholder returns by completing a $10.0 million share repurchase program in early 2026, part of a larger $30.0 million repurchase effort in 2025. Further reinforcing shareholder value, the Board increased the quarterly cash dividend by a notable 12.9%. The provided 2026 guidance offers a positive outlook for continued growth. Investors should view this comprehensive report as a strong signal of operational health, strategic expansion, and shareholder-friendly capital allocation.